Evidence map›Paper›PMID 41405327›Full record

ArticleInternational journal of surgery (London, England)2025

Deep cervical lymphatic-venous anastomosis in dementia: a clinical and mechanistic evaluation.

Cong Tang, Xiaoju Zheng, Haijun Li, Baoshan Wang, Yuqi Zheng, Wenbin Song, Aimei Wu, Linjun Xin, Dengwen Zhang, Rongguo Yang and 7 more

Abstract read
In one paragraph

Article in International journal of surgery (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Cong TangXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Xiaoju ZhengXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Haijun LiXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Baoshan WangXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Yuqi ZhengXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Wenbin SongXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Aimei WuXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Linjun XinXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Dengwen ZhangXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Rongguo YangXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Shuang DuXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Peng HeXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Yujiao LiXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Linjuan WuXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Xinrong WangXi'an Fengcheng Hospital, Xi'an, Shaanxi, China.
Qi ShiNova School of Business and Economics, Carcavelos, Portugal.
Gonçalo J L BernardesYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlzheimer's disease (AD) and other dementias are marked by progressive cognitive decline, with few effective treatments available in advanced stages. Impaired clearance of neurotoxic proteins such as amyloid-beta (Aβ) and tau is a central pathological feature. Deep cervical lymphatic-venous anastomosis (dcLVA) is a novel microsurgical approach designed to enhance cerebrospinal fluid (CSF) clearance via extracranial lymphatic pathways, potentially enabling removal of neurotoxic proteins.

objectiveTo evaluate the clinical effects and potential mechanisms of dcLVA in patients with advanced dementia, focusing on cognitive, functional, and immunopathological outcomes.

methodsTwenty-eight patients with advanced dementia underwent dcLVA. Cognitive performance was assessed using the Mini-Mental State Examination (MMSE), alongside evaluations of bowel and bladder control, emotional stability, behavioral responsiveness, and self-care abilities. Biological parameters-including CSF protein, tumor markers, lymphocyte counts, and peripheral blood concentrations of Aβ1-42 and phosphorylated tau-181 (P-tau181)-were measured pre- and postoperatively. Immunohistochemical analysis of resected cervical lymph nodes was performed to detect CNS-derived tau protein.

resultsWithin one week after dcLVA, 64.3% of patients demonstrated MMSE improvement, with further functional gains observed in continence, emotional regulation, motor coordination, and feeding independence. Patients with circulatory comorbidities were more likely to show cognitive recovery. Tau protein was detected in all examined cervical lymph nodes, providing direct histopathological evidence of CNS-derived pathological protein transport via the lymphatic system. In a subset of cognitively improved patients, peripheral lymphocyte counts normalized. In contrast, tumor markers and CSF total protein showed no significant correlation with outcomes.

conclusionsdcLVA may promote cognitive and functional recovery in patients with dementia by enhancing CNS waste clearance and modulating systemic immune responses. These exploratory findings describe postoperative changes observed in this cohort; however, the single-arm design precludes causal interpretation.

Indexed as

alzheimer’s diseasecentral nervous system clearancecognitive recoverydeep cervical lymphatic-venous anastomosisdementiaglymphatic systemimmune modulationmeningeal lymphaticsneurodegenerationtau protein

Identifiers

PMID41405327
PMCPMC13105595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.